1.
Montillo M, Cafro A, Tedeschi A, Brando B, Oreste P, Veronese S, Rossi V, Cairoli R, Pungolino E, Morra E. Safety and efficacy of subcutaneous Campath-1H for treating residual disease in patients with chronic lymphocytic leukemia responding to fludarabine. Haematologica [Internet]. 2002Jul.1 [cited 2026Nov.19];87(7):695-00. Available from: https://haematologica.org/article/view/2429